Bettina M. Cockroft - 21 Sep 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Issuer symbol
CNSP
Transactions as of
21 Sep 2023
Net transactions value
$0
Form type
4
Filing time
25 Sep 2023, 18:21:42 UTC
Previous filing
12 Oct 2023
Next filing
10 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNSP Option to purchase common stock Award +16,551 +28% 74,914 21 Sep 2023 Common Stock 18,650 $1.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
F2 The stock options were issued in connection with the reporting person's Board of Director services to the Company.